This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lavon, I. Articles by Ben-Neriah, Y. Search for Related Content PubMed PubMed Citation Articles by Lavon, I. Articles by Ben-Neriah, Y.

Nuclear Factor-B Protects the Liver against Genotoxic Stress and Functions Independently of p53¹

The Lautenberg Center for Immunology [I. L., E. G., Y. B-N.] and Department of Pathology [E. P.], The Hebrew University-Hadassah Medical School, Jerusalem 91120; Department of Pathology, Tel Aviv University Sackler Medical School and Sheba Medical Center, Tel-Hashomer 52621 [I. G.]; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, 76100 [J. B., M. O.], Israel

p53 and NF-B are two key effectors in the chemotherapy-induced genotoxic response. Although p53 is a universal inducer of apoptotosis in many stress responses, including the genotoxic response, the role of nuclear factor (NF)-B is not consistent and was reported to both counteract and mediate apoptosis. Although the reason for the apparent contradictory effects of NF-B is not understood, it may partly be related to the reported cross-regulation of NF-B and p53. Thus far, all studies exploring the cross-talk between p53 and NF-B in conjunction with apoptosis have been performed in tissue-cultured cells and may therefore not faithfully represent conditions that prevail within a chemotherapy-subjected organism. To address this concern, we examined the respective roles of NF-B and p53 in a liver model of doxorubicin-induced DNA damage. Using this animal model, we report that NF-B is activated in response to doxorubicin-induced genotoxic stress and exerts a pronounced protective effect in opposing chemotherapy-induced tissue damage. Importantly, the activation of NF-B occurs independently of p53 status. Furthermore, although p53 is also induced in this in vivo system, its induction is independent of NF-B and does not contribute to the extent of tissue damage. These findings may have important implications with respect to the potential use of NF-B modulators in cancer therapy.

This article has been cited by other articles:

				D. Nesic, R. Grumont, and S. Gerondakis The Nuclear Factor-{kappa}B and p53 Pathways Function Independently in Primary Cells and Transformed Fibroblasts Responding to Genotoxic Damage Mol. Cancer Res., July 1, 2008; 6(7): 1193 - 1203. [Abstract] [Full Text] [PDF]

				M. Katzenellenbogen, O. Pappo, H. Barash, N. Klopstock, L. Mizrahi, D. Olam, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, L. A. Mitchell, et al. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the mdr2-knockout mice. Cancer Res., April 15, 2006; 66(8): 4001 - 4010. [Abstract] [Full Text] [PDF]